Alzheimers Disease: – Positive Preclinical Efficacy Data with Alzheimer’s Disease Lead …

Positive Preclinical Efficacy Data with Alzheimer’s Disease Lead …
CNW Telbec (Communiqu s de presse), Canada - Feb 23, 2006… (“Transition”) (TSX: TTH) announced that a presentation of positive preclinical data with Alzheimer’s disease lead product AZD-103 was made at the Keystone …

Major biomarker candidates for Alzheimer’s disease explored
News-Medical.net, Australia - Mar 8, 2006Alzheimer’s disease – specific biomarkers clearly are needed for the differential diagnosis of cognitive impairment in the elderly. …

Stigma a hurdle in Alzheimer’s
Los Angeles Times, CA - 12 hours agoConcern over stigma and denial can delay diagnosis of Alzheimer’s disease for years, meaning patients do not receive treatment that could slow its progress …

Road is difficult for Alzheimer’s patients’ loved ones
Appleton Post Crescent,  USA - Mar 19, 2006When Bob and Betty McLeod of Neenah exchanged marriage vows more than 50 years ago, they never considered that Alzheimer’s disease might one day challenge that …

Latest Discoveries In Alzheimer’s Disease Therapy To Be Presented
Medical News Today (press release), UK - Mar 4, 2006The world’s leading physicians and scientists in the fields of Alzheimer’s disease treatment and dementia research will participate in the 9th International …

PhytoMedical Enters Into Expanded Collaborative Agreement For Type …
Genetic Engineering News, NY - Mar 21, 2006… existing research activities, but also to expand the scope of those activities to study the possible applicability of our compounds to Alzheimer’s disease.”. …

Related posts:

  1. Alzheimer’s disease research could lead to easier detection in a few years
  2. Alzheimers Disease: – New Data Shows Death Rates from Alzheimer’s Disease Skyrocketing
  3. Mapping genes could lead to breakthrough in Alzheimer’s disease treatment
  4. Alzheimer’s vaccine – First evidence for efficacy
  5. Alzheimers Disease: – Minimum of exercise can lead to big health boost

Leave a Reply